Active Ingredient: MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
Proprietary Name: RYALTRIS
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 0.025MG/SPRAY;0.665MG/SPRAY
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211746
Product Number: 001
Approval Date: Jan 13, 2022
Applicant Holder Full Name: GLENMARK SPECIALTY SA
Marketing Status:
Prescription
Patent and Exclusivity Information
